Literature DB >> 17685603

Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5.

Roberto Pellicciari1, Hiroyuki Sato, Antimo Gioiello, Gabriele Costantino, Antonio Macchiarulo, Bahman M Sadeghpour, Gianluca Giorgi, Kristina Schoonjans, Johan Auwerx.   

Abstract

23-Alkyl-substituted and 6,23-alkyl-disubstituted derivatives of chenodeoxycholic acid are identified as potent and selective agonists of TGR5, a G-protein coupled receptor for bile acids (BAs). In particular, we show that methylation at the C-23(S) position of natural BAs confers a marked selectivity for TGR5 over FXR, while the 6alpha-alkyl substitution increases the potency at both receptors. The present results allow for the first time a pharmacological differentiation of genomic versus nongenomic effects mediated by BA derivatives.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17685603     DOI: 10.1021/jm070633p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  32 in total

1.  The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice.

Authors:  Yan-Dong Wang; Wei-Dong Chen; Donna Yu; Barry M Forman; Wendong Huang
Journal:  Hepatology       Date:  2011-08-11       Impact factor: 17.425

2.  Bile alcohols function as the ligands of membrane-type bile acid-activated G protein-coupled receptor.

Authors:  Yusuke Iguchi; Masafumi Yamaguchi; Hiroyuki Sato; Kenji Kihira; Tomoko Nishimaki-Mogami; Mizuho Une
Journal:  J Lipid Res       Date:  2009-12-18       Impact factor: 5.922

Review 3.  Bile Acid Metabolism in Liver Pathobiology.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Gene Expr       Date:  2018-01-11

4.  G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes.

Authors:  Xiaoxin X Wang; Michal Herman Edelstein; Uzi Gafter; Liru Qiu; Yuhuan Luo; Evgenia Dobrinskikh; Scott Lucia; Luciano Adorini; Vivette D D'Agati; Jonathan Levi; Avi Rosenberg; Jeffrey B Kopp; David R Gius; Moin A Saleem; Moshe Levi
Journal:  J Am Soc Nephrol       Date:  2015-09-30       Impact factor: 10.121

5.  Probing the Binding Site of Bile Acids in TGR5.

Authors:  Antonio Macchiarulo; Antimo Gioiello; Charles Thomas; Thijs W H Pols; Roberto Nuti; Cristina Ferrari; Nicola Giacchè; Francesca De Franco; Mark Pruzanski; Johan Auwerx; Kristina Schoonjans; Roberto Pellicciari
Journal:  ACS Med Chem Lett       Date:  2013-10-15       Impact factor: 4.345

6.  Avicholic Acid: A Lead Compound from Birds on the Route to Potent TGR5 Modulators.

Authors:  Roberto Pellicciari; Antimo Gioiello; Paola Sabbatini; Francesco Venturoni; Roberto Nuti; Carolina Colliva; Giovanni Rizzo; Luciano Adorini; Mark Pruzanski; Aldo Roda; Antonio Macchiarulo
Journal:  ACS Med Chem Lett       Date:  2012-02-06       Impact factor: 4.345

7.  Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid-Treated Animals Receiving Parenteral Nutrition.

Authors:  Ajay Kumar Jain; Abhineet Sharma; Sumit Arora; Keith Blomenkamp; Ik Chan Jun; Robert Luong; David John Westrich; Aayush Mittal; Paula M Buchanan; Miguel A Guzman; John Long; Brent A Neuschwander-Tetri; Jeffery Teckman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-08-20       Impact factor: 4.016

8.  Deficiency of G-protein-coupled bile acid receptor Gpbar1 (TGR5) enhances chemically induced liver carcinogenesis.

Authors:  Wei-Dong Chen; Donna Yu; Barry M Forman; Wendong Huang; Yan-Dong Wang
Journal:  Hepatology       Date:  2013-02       Impact factor: 17.425

Review 9.  Bile acids: regulation of synthesis.

Authors:  John Y L Chiang
Journal:  J Lipid Res       Date:  2009-04-03       Impact factor: 5.922

Review 10.  Bile acid metabolism and signaling.

Authors:  John Y L Chiang
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.